Literature DB >> 23769778

Intacs with or without same-day corneal collagen cross-linking to treat corneal ectasia.

Marie Eve Legare1, Alfonso Iovieno, Sonia N Yeung, Alejandro Lichtinger, Peter Kim, Simon Hollands, Allan R Slomovic, David S Rootman.   

Abstract

OBJECTIVE: To compare combined intrastromal corneal ring segment implantation with same-day ultraviolet-A/riboflavin corneal collagen cross-linking (ICRS-CXL) versus ICRS implantation alone in patients with corneal ectasia.
DESIGN: Retrospective comparative study. PARTICIPANTS: Sixty-six eyes from 54 patients with corneal ectasia were included in the study. The groups were composed of 32 eyes from 27 patients and 34 eyes from 27 patients for the ICRS-CXL and ICRS groups, respectively.
METHODS: We reviewed the charts of all patients who underwent these procedures from November 2008 to February 2011 for preoperative and for up to 1 year postoperative uncorrected (UDVA) and best corrected distance visual acuity (BDVA), refraction, topographical analysis (mean and steepest keratometry [K]), as well as root mean-square (RMS) of higher-order aberrations (HOAs).
RESULTS: Overall, a significant improvement was seen in both groups for UDVA, BDVA, sphere, cylinder, mean refractive spherical equivalent (MRSE), mean and steepest K, coma, spherical and total HOA at 12 months. Trefoil did not improve, and higher-order astigmatism worsened in the ICRS group (p = 0.0466). There was no statistically significant difference between the 2 groups for visual acuity, sphere, cylinder, coma, trefoil, and spherical HOA. Outcomes were significantly more improved in the ICRS group for MRSE (p = 0.0082), mean K (p = 0.0021), steepest K (p = 0.0152), and total HOAs (p = 0.0208). No complications were observed.
CONCLUSIONS: ICRS-CXL and ICRS alone were both safe and effective in treating corneal ectasia. The ICRS alone group demonstrated better outcomes of MRSE, mean and steepest K, as well as total HOA.
Copyright © 2013 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23769778     DOI: 10.1016/j.jcjo.2013.02.001

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  6 in total

Review 1.  Femtosecond laser-assisted stromal keratophakia for keratoconus: A systemic review and meta-analysis.

Authors:  Andri K Riau; Hla Myint Htoon; Jorge L Alió Del Barrio; Mario Nubile; Mona El Zarif; Leonardo Mastropasqua; Jorge L Alió; Jodhbir S Mehta
Journal:  Int Ophthalmol       Date:  2021-02-20       Impact factor: 2.031

2.  Efficacy of complete rings (MyoRing) in treatment of Keratoconus: a systematic review and meta-analysis.

Authors:  Leila Janani; Kiarash Tanha; Fereshteh Najafi; Khosrow Jadidi; Farhad Nejat; Seyed Javad Hashemian; Mohsen Dehghani; Masoumeh Sadeghi
Journal:  Int Ophthalmol       Date:  2019-06-01       Impact factor: 2.031

Review 3.  Updates on Managements for Keratoconus.

Authors:  Mehrdad Mohammadpour; Zahra Heidari; Hassan Hashemi
Journal:  J Curr Ophthalmol       Date:  2017-12-06

Review 4.  Corneal cross-linking (CXL) combined with refractive surgery for the comprehensive management of keratoconus: CXL plus.

Authors:  Vardhaman P Kankariya; Ankita B Dube; Michael A Grentzelos; George A Kontadakis; Vasilios F Diakonis; Myrsini Petrelli; George D Kymionis
Journal:  Indian J Ophthalmol       Date:  2020-12       Impact factor: 1.848

Review 5.  Updates on corneal collagen cross-linking: Indications, techniques and clinical outcomes.

Authors:  Mehrdad Mohammadpour; Ahmad Masoumi; Masoud Mirghorbani; Kianoosh Shahraki; Hassan Hashemi
Journal:  J Curr Ophthalmol       Date:  2017-09-12

6.  Effect of Sequential Intrastromal Corneal Ring Segment Implantation and Corneal Collagen Crosslinking in Corneal Ectasia.

Authors:  Chung Young Kim; Mee Kum Kim
Journal:  Korean J Ophthalmol       Date:  2019-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.